 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: compound 6p [PMID: 38551814]
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: SI-10 is a small molecule that is designed to inhibit the oncogenic actions of nuclear receptor coactivator 3 (NCOA3; SRC3) [1]. Direct interaction between SI-10 and NCOA3 was determined in an estrogen receptor (ER) binding element (ERE) pull-down assay, and the NCOA3-dependency of its antiproliferative effect was demonstrated using lentivirus-mediated shRNA knock-down.  SI-10 functions by disrupting recruitment of NCOA3 to the steroid receptor transcriptional complex, to ultimately reduce steroid receptor-regulated gene transcription in relevant tumours.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| SI-10 inhibits proliferation breast cancer and prostate cancer cells in vitro [1]. In vivo antitumour activity of orally administered SI-10 has been demonstrated in prostate and pancreatic cancer xenograft models. The compound has favourable pharmacokinetic, off-target and toxicity profiles; hERG inhibition is >30 μM, half-life is ~9 hours in mice (orally delivered). | 
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||